CD133 immunomagnetic separation: Effectiveness of the method for CD133 + isolation from umbilical cord blood

Cytotherapy

Volumn 14, Issue 6, 2012, Pages 701-706

  Pelagiadis, Iordanis ^a   Relakis, Konstantinos ^b   Kalmanti, Lida ^a   Dimitriou, Helen ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

CD133; CD34; Hematopoietic stem progenitor cells; Immunomagnetic isolation method

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; PHYCOERYTHRIN;

ANTIGEN EXPRESSION; ARTICLE; CELL FRACTIONATION; CELL ISOLATION; CELL POPULATION; CLINICAL PROTOCOL; CONTROLLED STUDY; GLYCOSYLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MONONUCLEAR CELL; PRIORITY JOURNAL; REPRODUCIBILITY; UMBILICAL CORD BLOOD;

EID: 84862219743     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.663487     Document Type: Article

References (21)

1. Rowe JM. Optimal management of adults with ALL. Br J Haematol. 2009;144:468-83.
2. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in fi rst complete remission: systematic review and meta-analysis of prospective clinical trials. J Am Med Assoc (JAMA). 2009;30:2349-61.
3. Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009;113:6288-95.
4. Filipovich A. Hematopoietic cell transplantation for correction of primary immunodefi ciencies. Bone Marrow Transplant. 2008;42(Suppl 1):S49-52.
5. Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica. 2009;94:451-4.
6. icardi A, Arcese W. Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. Transfus Apher Sci. 2010;42:289-97.
7. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87:1-13. (Pubitemid 26018389)
8. Bauer N, Fonseca AV, Florek M, Freund D, Jaszai J, Bornhauser M, et al. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs. 2008;188:127-38. (Pubitemid 351962236)
9. + ) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther. 2010;10:1521-8.
10. + )Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 2000;95:2813-20. (Pubitemid 30235890)
11. + ) cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO). Potential implications for hematopoietic cell transplantation. Leuk Res. 2003;27:1143-51. (Pubitemid 36960034)
12. Robinson SN, Ng J, Niu T, Yang H, McMannis JD, Karandish S, et al. Superior ex vivo cord blood expansion following coculture with bone marrow-derived mesenchymal stem cell. Bone Marrow Transplant. 2006;37:359-66. (Pubitemid 43250469)
13. Singh K, Srivastava, A, Mathur N, Kumar S, Kumar L, Mukhopadhyay A, et al. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method. Cytotherapy. 2009;11:768-77.
14. + cells better at improving cardiac function? Exp Biol Med. 2010;235:119-29.
15. Kekarainen T, Mannelin S, Laine J, Jaatinen T. Optimization of immunomagnetic separation for cord blood-derived hemato poietic stem cells. BMC Cell Biol. 2006;7:30-9.
16. Jing Y, Moore LR, Schneider T, Williams PS, Chalmers JJ, Farag SS, et al. Negative selection of hematopoietic progenitor cells by continuous magnetophoresis. Exp Hematol. 2007; 35:662-72. (Pubitemid 46427963)
17. + cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using fi ve separation systems. Stem Cells. 1995;13:524-32.
18. Roviita P, Teramo K, Hiilesmaa V, Kekomaki R. Cord blood hematopoietic progenitor cell concentration and infant sex. Transfusion. 2005;45:613-21.
19. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002-12. (Pubitemid 28007217)
20. Green CL, Loken M, Buck D, Deeg HJ. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML). Leukemia. 2000;14:770-2. (Pubitemid 30195474)
21. Miyoshi E, Noda K, Ko JH, Ekuni A, Kitada T, Uozumi N, et al. Overexpression of alpha1 -6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res. 1999;59:2237-43. (Pubitemid 29217691)